Copyright
©The Author(s) 2017.
World J Hepatol. Aug 18, 2017; 9(23): 1001-1007
Published online Aug 18, 2017. doi: 10.4254/wjh.v9.i23.1001
Published online Aug 18, 2017. doi: 10.4254/wjh.v9.i23.1001
Table 6 Sensitivity, specificity, positive prediction value, negative prediction value and accuracy of microRNAs and α-feto protein
| Variable(s) | Cutoff value | Sensitivity% | Specificity% | Positive predictive value (PPV%) | Negative predictive value (NPV%) | Accuracy |
| MicroRNA 23a | ≥ 210 | 89.47% | 64.91% | 56.04% | 92.5% | 79.3% |
| MicroRNA 34 | ≥ 210 | 89.47% | 55.26% | 50% | 91.3% | 79.3% |
| MicroRNA 203 | ≥ 24 | 80.7% | 10.53% | 31.08% | 52.17% | 29.6% |
| MicroRNA 338 | ≥ 25 | 63.16% | 16.67% | 27.48% | 47.5% | 26.4% |
| MicroRNA 16 | ≥ 210 | 87.72% | 57.89% | 51.02% | 90.4% | 75.7% |
| α-feto protein | ≥ 200 | 73.68% | 52.63% | 43.75% | 80% | 78.5% |
- Citation: Mohamed AA, Ali-Eldin ZA, Elbedewy TA, El-Serafy M, Ali-Eldin FA, AbdelAziz H. MicroRNAs and clinical implications in hepatocellular carcinoma. World J Hepatol 2017; 9(23): 1001-1007
- URL: https://www.wjgnet.com/1948-5182/full/v9/i23/1001.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i23.1001